SEC Form 4 · accession 0001493152-26-028589
CytoMed Therapeutics Ltd · GDTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chee Kong Choo
Director · 10% Owner
Period of report
Jun 8, 2026
Accepted (ET)
Jun 15, 2026 · 6:15 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001873093
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, no par value per share | May 13, 2026 | P | 112,000 | $1.1498 | A | 430,324 | D |
Table II — derivative securities
No Table II lines on this filing.